InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Yeleswaram Krishnaswamy. Officer active across 1 company, notably Rapport Therapeutics, Inc.. In total, 7 disclosures have been published. Breakdown: 0 buy · 6 sells. Total volume traded: €1.5m. Activity tracked since 25 March 2026. The latest transaction was filed on 17 April 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
7 of 7 declarations
Yeleswaram Krishnaswamy is a declarant with 5 filings in total. In the 5 recent filings we hold, all transactions are sales, for a total of EUR 1,287,795, from 2026-04-09 to 2026-04-21, all related to Rapport Therapeutics, Inc., where he is Chief Development Officer.